MicroRNA-22-3p as a novel regulator and therapeutic target for autoimmune diseases

References

• Wahren-Herlenius M, Dorner T. Immunopathogenic mechanisms of systemic autoimmune disease. Lancet 2013;382(9894):819–831.
   PubMed Web of Science ®Google Scholar
• Goldblatt F, O'Neill SG. Clinical aspects of autoimmune rheumatic diseases. Lancet 2013;382(9894):797–808.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet 2016.
   Google Scholar
• Talaat RM, Mohamed SF, Bassyouni IH, Raouf AA. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity. Cytokine 2015;72(2):146–153.
   PubMed Web of Science ®Google Scholar
• Noack M, Miossec P. Th17 and regulatory T cell balance in autoimmune and inflammatory diseases. Autoimmun Rev 2014;13(6):668–677.
   PubMed Web of Science ®Google Scholar
• Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 2014;15(8):509–524.
   PubMed Web of Science ®Google Scholar
• Jonas S, Izaurralde E. Towards a molecular understanding of microRNA-mediated gene silencing. Nat Rev Genet 2015;16(7):421–433.
   PubMed Web of Science ®Google Scholar
• Hausser J, Zavolan M. Identification and consequences of miRNA-target interactions–beyond repression of gene expression. Nat Rev Genet 2014;15(9):599–612.
   PubMed Web of Science ®Google Scholar
• Vicente R, Noel D, Pers YM, Apparailly F, Jorgensen C. Deregulation and therapeutic potential of microRNAs in arthritic diseases. Nat Rev Rheumatol 2016;12(4):211–220.
   PubMed Web of Science ®Google Scholar
• McManus DD, Freedman JE. MicroRNAs in platelet function and cardiovascular disease. Nat Rev Cardiol 2015;12(12), 711–717.
   PubMed Web of Science ®Google Scholar
• Baumjohann D, Ansel KM. MicroRNA-mediated regulation of T helper cell differentiation and plasticity. Nat Rev Immunol 2013;13(9):666–678.
   PubMed Web of Science ®Google Scholar
• Pagani M, Rossetti G, Panzeri I et al. Role of microRNAs and long-non-coding RNAs in CD4(+) T-cell differentiation. Immunol Rev 2013;253(1):82–96.
   PubMed Web of Science ®Google Scholar
• Mehta A, Baltimore D. MicroRNAs as regulatory elements in immune system logic. Nat Rev Immunol 2016;16(5), 279–294.
   PubMed Web of Science ®Google Scholar
• Turner M, Galloway A, Vigorito E. Noncoding RNA and its associated proteins as regulatory elements of the immune system. Nat Immunol 2014;15(6):484–491.
   PubMed Web of Science ®Google Scholar
• Gurha P, Abreu-Goodger C, Wang T et al. Targeted deletion of microRNA-22 promotes stress-induced cardiac dilation and contractile dysfunction. Circulation 2012;125(22):2751–2761.
   PubMed Web of Science ®Google Scholar
• Song SJ, Poliseno L, Song MS et al. MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling. Cell 2013;154(2):311–324.
   PubMed Web of Science ®Google Scholar
• You Y, Tan JX, Dai HS et al. MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma. Oncotarget 2016.
   Web of Science ®Google Scholar
• Garo LP, Murugaiyan G. Contribution of MicroRNAs to autoimmune diseases. Cell Mol Life Sci 2016;73(10):2041–2051.
   PubMed Web of Science ®Google Scholar
• Chen CZ, Schaffert S, Fragoso R, Loh C. Regulation of immune responses and tolerance: the microRNA perspective. Immunol Rev 2013;253(1):112–128.
   PubMed Web of Science ®Google Scholar
• Shu Y, Hu Q, Long H, Chang C, Lu Q, Xiao R. Epigenetic variability of CD4+CD25+ tregs contributes to the pathogenesis of autoimmune diseases. Clin Rev Allergy Immunol 2016.
   Web of Science ®Google Scholar
• Takahashi N, Nakaoka T, Yamashita N. Profiling of immune-related microRNA expression in human cord blood and adult peripheral blood cells upon proinflammatory stimulation. Eur J Haematol 2012;88(1):31–38.
   PubMed Web of Science ®Google Scholar
• Liu C, Iqbal J, Teruya-Feldstein J, et al. MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma. Blood 2013;122(12):2083–2092.
   PubMed Web of Science ®Google Scholar
• Jiang X, Hu C, Arnovitz S et al. miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia. Nat Commun 2016;7:11452.
   PubMed Web of Science ®Google Scholar
• Fontemaggi G, Bellissimo T, Donzelli S et al. Identification of post-transcriptional regulatory networks during myeloblast-to-monocyte differentiation transition. RNA Biol 2015;12(7):690–700.
   PubMed Web of Science ®Google Scholar
• Shen C, Chen MT, Zhang XH et al. The PU.1-modulated MicroRNA-22 Is a regulator of Monocyte/macrophage differentiation and acute myeloid leukemia. PLoS Genet 2016;12(9):e1006259.
   PubMed Web of Science ®Google Scholar
• Liu WH, Kang SG, Huang Z et al. A miR-155-Peli1-c-Rel pathway controls the generation and function of T follicular helper cells. J Exp Med 2016;213(9):1901–1919.
   PubMed Web of Science ®Google Scholar
• Mangala LS, Zhang Y, He Z et al. Effects of simulated microgravity on expression profile of microRNA in human lymphoblastoid cells. J Biol Chem 2011;286(37);32483–32490.
   PubMed Web of Science ®Google Scholar
• Li HS, Greeley N, Sugimoto N, Liu YJ, Watowich SS. miR-22 controls Irf8 mRNA abundance and murine dendritic cell development. PLoS One 2012;7(12):e52341.
   PubMed Web of Science ®Google Scholar
• Riepsaame J, van Oudenaren A, den Broeder BJ, van Ijcken WF, Pothof J, Leenen PJ. MicroRNA-mediated down-regulation of M-CSF receptor contributes to maturation of mouse Monocyte-derived dendritic cells. Front Immunol 2013;4:353.
   PubMed Web of Science ®Google Scholar
• Pearce EJ, Everts B. Dendritic cell metabolism. Nat Rev Immunol 2015;15(1), 18–29.
   PubMed Web of Science ®Google Scholar
• Coutant F, Miossec P. Altered dendritic cell functions in autoimmune diseases: distinct and overlapping profiles. Nat Rev Rheumatol 2016.
   Web of Science ®Google Scholar
• Min S, Liang X, Zhang M et al. Multiple tumor-associated microRNAs modulate the survival and longevity of dendritic cells by targeting YWHAZ and Bcl2 signaling pathways. J Immunol 2013;190(5):2437–2446.
   PubMed Web of Science ®Google Scholar
• Liang X, Liu Y, Mei S et al. MicroRNA-22 impairs anti-tumor ability of dendritic cells by targeting p38. PLoS One 2015;10(3):e0121510.
   PubMed Web of Science ®Google Scholar
• Lu W, You R, Yuan X et al. The microRNA miR-22 inhibits the histone deacetylase HDAC4 to promote T(H)17 cell-dependent emphysema. Nat Immunol 2015;16(11), 1185–1194.
   PubMed Web of Science ®Google Scholar
• Wu XN, Ye YX, Niu JW et al. Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus. Sci Transl Med 2014;6(246):246ra299.
   Web of Science ®Google Scholar
• Park CO, Kupper TS. The emerging role of resident memory T cells in protective immunity and inflammatory disease. Nat Med 2015;21(7):688–697.
   PubMed Web of Science ®Google Scholar
• DuPage M, Bluestone JA. Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease. Nat Rev Immunol 2016;16(3):149–163.
   PubMed Web of Science ®Google Scholar
• Ma X, Zhou J, Zhong Y et al. Expression, regulation and function of microRNAs in multiple sclerosis. Int J Med Sci 2014;11(8):810–818.
   PubMed Web of Science ®Google Scholar
• Rouse M, Rao R, Nagarkatti M, Nagarkatti PS. 3,3'-diindolylmethane ameliorates experimental autoimmune encephalomyelitis by promoting cell cycle arrest and apoptosis in activated T cells through microRNA signaling pathways. J Pharmacol Exp Ther 2014;350(2):341–352.
   PubMed Web of Science ®Google Scholar
• De Santis G, Ferracin M, Biondani A et al. Altered miRNA expression in T regulatory cells in course of multiple sclerosis. J Neuroimmunol 2010;226(1, 2):165–171.
   PubMed Web of Science ®Google Scholar
• Di Marco Barros R, Roberts NA, Dart RJ et al. Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific gammadelta T Cell Compartments. Cell 2016;167(1):203–218, e217.
   PubMed Web of Science ®Google Scholar
• Rosser EC, Oleinika K, Tonon S et al. Regulatory B cells are induced by gut microbiota-driven interleukin-1beta and interleukin-6 production. Nat Med 2014;20(11):1334–1339.
   PubMed Web of Science ®Google Scholar
• Song RH, Yu ZY, Qin Q et al. Different levels of circulating Th22 cell and its related molecules in Graves' disease and Hashimoto's thyroiditis. Int J Clin Exp Pathol 2014;7(7):4024–4031.
   PubMed Web of Science ®Google Scholar
• Wang RX, Yu CR, Dambuza IM et al. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat Med 2014;20(6):633–641.
   PubMed Web of Science ®Google Scholar
• Qin Q, Liu P, Liu L et al. The increased but non-predominant expression of Th17- and Th1-specific cytokines in Hashimoto's thyroiditis but not in Graves' disease. Braz J Med Biol Res 2012;45(12), 1202–1208.
   PubMed Web of Science ®Google Scholar
• Alevizos I, Illei GG. MicroRNAs as biomarkers in rheumatic diseases. Nat Rev Rheumatol 2010;6(7):391–398.
   PubMed Web of Science ®Google Scholar
• Guay C, Regazzi R. Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat Rev Endocrinol 2013;9(9):513–521.
   PubMed Web of Science ®Google Scholar
• Patel M, Verma A, Aslam I, Pringle H, Singh B. Novel plasma microRNA biomarkers for the identification of colitis-associated carcinoma. Lancet 2015;385(Suppl 1):S78.
   PubMedGoogle Scholar
• Shen N, Liang D, Tang Y, de Vries N, Tak PP. MicroRNAs–novel regulators of systemic lupus erythematosus pathogenesis. Nat Rev Rheumatol 2012;8(12):701–709.
   PubMed Web of Science ®Google Scholar
• Chen JQ, Papp G, Szodoray P, Zeher M. The role of microRNAs in the pathogenesis of autoimmune diseases. Autoimmun Rev 2016.
   Web of Science ®Google Scholar
• Lin J, Huo R, Xiao L et al. A novel p53/microRNA-22/Cyr61 axis in synovial cells regulates inflammation in rheumatoid arthritis. Arthritis Rheumatol 2014;66(1):49–59.
   PubMed Web of Science ®Google Scholar
• Krintel SB, Dehlendorff C, Hetland ML et al. Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis. Pharmacogenomics J 2016;16(2):141–146.
   PubMed Web of Science ®Google Scholar
• Wang W, Mou S, Wang L et al. Up-regulation of serum MiR-130b-3p Level is associated with renal damage in early lupus nephritis. Sci Rep 2015;5:12644.
   PubMed Web of Science ®Google Scholar
• Yamada H, Itoh M, Hiratsuka I, Hashimoto S. Circulating microRNAs in autoimmune thyroid diseases. Clin Endocrinol (Oxf) 2014;81(2):276–281.
   PubMed Web of Science ®Google Scholar
• Qin Q, Wang X, Yan N et al. Aberrant expression of miRNA and mRNAs in lesioned tissues of Graves' disease. Cell Physiol Biochem 2015;35(5):1934– 1942.
   PubMed Web of Science ®Google Scholar
• Hiratsuka I, Yamada H, Munetsuna E, Hashimoto S, Itoh M. Circulating microRNAs in graves' disease in relation to clinical activity. Thyroid 2016.
   Web of Science ®Google Scholar
• Estrella S, Garcia-Diaz DF, Codner E, Camacho-Guillen P, Perez-Bravo F. [Expression of miR-22 and miR-150 in type 1 diabetes mellitus: Possible relationship with autoimmunity and clinical characteristics]. Med Clin (Barc) 2016.
   Web of Science ®Google Scholar
• Junker A, Krumbholz M, Eisele S et al. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 2009;132(Pt 12):3342–3352.
   PubMed Web of Science ®Google Scholar
• Siegel SR, Mackenzie J, Chaplin G, Jablonski NG, Griffiths L. Circulating microRNAs involved in multiple sclerosis. Mol Biol Rep 2012;39(5):6219–6225.
   PubMed Web of Science ®Google Scholar
• Dong X, Xu M, Ren Z et al. Regulation of CBL and ESR1 expression by microRNA-22-3p, 513a-5p and 625-5p may impact the pathogenesis of dust mite-induced pediatric asthma. Int J Mol Med 2016;38(2):446–456.
   PubMed Web of Science ®Google Scholar
• Takenaka MC, Quintana FJ. Tolerogenic dendritic cells. Semin Immunopathol 2016.
   Web of Science ®Google Scholar
• Burkett PR, Meyer zu Horste G, Kuchroo VK. Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity. J Clin Invest 2015;125(6):2211–2219.
   PubMed Web of Science ®Google Scholar
• Luu VP, Vazquez MI, Zlotnik A. B cells participate in tolerance and autoimmunity through cytokine production. Autoimmunity 2014;47(1):1–12.
   PubMed Web of Science ®Google Scholar
• Tangye SG, Ma CS, Brink R, Deenick EK. The good, the bad and the ugly - TFH cells in human health and disease. Nat Rev Immunol 2013;13(6):412–426.
   PubMed Web of Science ®Google Scholar
• Spence A, Klementowicz JE, Bluestone JA, Tang Q. Targeting treg signaling for the treatment of autoimmune diseases. Curr Opin Immunol 2015;37:11–20.
   PubMed Web of Science ®Google Scholar
• Lin J, Zhou Z, Huo R et al. Cyr61 induces IL-6 production by fibroblast-like synoviocytes promoting Th17 differentiation in rheumatoid arthritis. J Immunol 2012;188(11):5776–5784.
   PubMed Web of Science ®Google Scholar
• Li Z, Rana TM. Therapeutic targeting of microRNAs: current status and future challenges. Nat Rev Drug Discov 2014;13(8):622–638.
   PubMed Web of Science ®Google Scholar
• Matin F, Jeet V, Clements JA, Yousef GM, Batra J. MicroRNA theranostics in prostate cancer precision medicine. Clin Chem 2016;62(10):1318– 1333.
   PubMed Web of Science ®Google Scholar
• Cheng CJ, Bahal R, Babar IA et al. MicroRNA silencing for cancer therapy targeted to the tumour microenvironment. Nature 2015;518(7537):107–110.
   PubMed Web of Science ®Google Scholar